Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solitaire™ FR With the Intention For Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Clinical Trial

NCT01657461 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.

NCT NCT01657461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solitaire™ FR With the Intention For Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Clinical Trial
Lead sponsor
Medtronic Neurovascular Clinical Affairs
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2012
Completion date
January 31, 2015
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke